immtechpharma.com

Immtech Pharmaceuticals, Inc.

To have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community. The infectious diseases market represents an estimated US$46 billion in annual sales. Learn about Immtech Pharmaceuticals:. Our history, proprietary technology platform, products and prospects. Go to Press Releases.

http://www.immtechpharma.com/

OVERVIEW OF immtechpharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMTECHPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 9 reviews

5 star

2

4 star

4

3 star

3

2 star

0

1 star

0

Hey there! Start your review of immtechpharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.4 seconds

FAVICON PREVIEW

16x16

CONTACTS AT IMMTECHPHARMA.COM

Immtech International

150 Fa●●●●●● Drive

Vern●●●●ills , IL, 60061

US

1.84●●●●0033

no●●●●●●●●●●●●@worldnic.com

View this contact

Immtech International

Immtech International

150 Fa●●●●●● Drive

Vern●●●●ills , IL, 60061

US

1.84●●●●0033

mi●●●●●●@gmail.com

View this contact

Immtech International

Immtech International

150 Fa●●●●●● Drive

Vern●●●●ills , IL, 60061

US

1.84●●●●0033

mi●●●●●●@gmail.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 September 22
UPDATED: 2013 August 02
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

18

YEARS
8

MONTHS
17

DAYS

NAME SERVERS

1: ns57.worldnic.com
2: ns58.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

10

SSL

EXTERNAL LINKS

1

SITE IP

206.188.193.124

LOAD TIME

0.423 sec

SCORE

6.2

PAGE TITLE

Immtech Pharmaceuticals, Inc. | immtechpharma.com Reviews

<META> DESCRIPTION

To have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community. The infectious diseases market represents an estimated US$46 billion in annual sales. Learn about Immtech Pharmaceuticals:. Our history, proprietary technology platform, products and prospects. Go to Press Releases.

<META> KEYWORDS

1 immtech pharmaceuticals aims

2 company information

3 company overview

4 executive team

5 board of directors

6 corporate governance

7 career opportunities

8 company faqs

9 investor center

10 opportunities

CONTENT

Page content here

KEYWORDS ON PAGE

immtech pharmaceuticals aims,company information,company overview,executive team,board of directors,corporate governance,career opportunities,company faqs,investor center,opportunities,technology,sec filings,investor faqs,press room,terms of use

SERVER

openresty/1.11.2.4

CONTENT-TYPE

iso-8859-1

GOOGLE PREVIEW

Immtech Pharmaceuticals, Inc. | immtechpharma.com Reviews

https://immtechpharma.com

To have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community. The infectious diseases market represents an estimated US$46 billion in annual sales. Learn about Immtech Pharmaceuticals:. Our history, proprietary technology platform, products and prospects. Go to Press Releases.

INTERNAL PAGES

immtechpharma.com

1

Immtech Pharmaceuticals, Inc.

http://www.immtechpharma.com/investors.html

We aim to deliver a high-growth pipeline of new potential products, protected by an extensive portfolio of issued patents and patent applications. Immtech is focused on an opportunity inadequately covered by large pharmaceutical. Companies: the development and commercialization of oral drugs to treat infectious. Diseases in developed as well as developing markets. Infectious diseases collectively. Affect billions of people, and the potential sales opportunities are substantial.

2

Immtech Pharmaceuticals, Inc.

http://www.immtechpharma.com/policy.html

We are very sensitive to the privacy concerns of our visitors and we recognize that you are concerned about the information you provide us, and how we treat such information. This Privacy Policy explains the type of information that is collected on this website, and how we use and protect it. We will take reasonable steps to keep all information as secure as possible against unauthorized access and use. All information will be protected by our security measures, which are periodically reviewed.

3

Immtech Pharmaceuticals, Inc.

http://www.immtechpharma.com/business_model.html

We target cures for diseases. Of people, and. Are significant unmet needs. Immtech has a cost-effective drug development paradigm in the. Targeting Diseases in Need of New Treatments. We aim to develop cures for infectious diseases that affect the global community. And for which there are significant unmet needs. Although the infectious disease. Market represents an estimated US$46 billion in annual sales, relatively few new. Accelerating the Pace, and Reducing the Cost, of Commercialization.

4

Immtech Pharmaceuticals, Inc.

http://www.immtechpharma.com/business_development.html

We look for opportunities to develop strategic partnerships and alliances. Partnerships with other pharmaceutical companies and international health. Organizations could provide an established distribution presence for Immtech. Pharmaceuticals in developed and developing markets, as well as specific expertise. Or access to a partner drug. Our ongoing drug discovery. Activities include programs in. Hepatitis C (HCV), fungal diseases and multi-drug resistant strains of bacterial.

5

Immtech Pharmaceuticals, Inc.

http://www.immtechpharma.com/newsreleases.html

Immtech To Be Listed on OTC Market. Immtech To Reorganize Research And Development Operations. Immtech Announces Investment In China. Immtech Receives Listing Determination Letter. Immtech And Beijing Pharmaceutical Group Co. Sign Memorandum Of Understanding To Explore Developing Strategic Business Alliance. Immtech To Reschedule Quarterly Conference Call. Immtech Reports Fiscal Third Quarter 2009 Results. Immtech Announces Appointment Of Virchow Krause As Independent Registered Public Accounting Firm.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

mymanheb.blogspot.com

My Man: July 2009

http://mymanheb.blogspot.com/2009_07_01_archive.html

Learn how to make money the MYMAN way and learn how to live the MYMAN lifestyle by following, MYMAN. MYMAN cares about one thing and one thing only: Makin' money and having the ladies, my man. Get Rich or Die Tryin'. Friday, July 31, 2009. MYMAN is spending HTDS money on the ladies this weekend, my man. MYMAN rates MedaSorb Technologies (MSBT) a BUY. MYMAN's quick picks, my man. Got some money to invest, my man? You won't go wrong if you invest that money in some of these, my man:. Focuses on the discove...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

1

OTHER SITES

immtech.biz

Immtech Pharmaceuticals, Inc.

To have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community. The infectious diseases market represents an estimated US$46 billion in annual sales. Learn about Immtech Pharmaceuticals:. Our history, proprietary technology platform, products and prospects. Go to Press Releases.

immtech.com

Immedia Technologies Inc.

We offer a full range of analysis services to ensure that your desires and goals are properly documented. We have a wide range of experience in software development including a number of different technologies and platforms including:. It doesn't take much for an IT project to come off the rails. We have the experience in IT project management to keep your project on time and on budget. Here is a partial list of our past and current clients:. Department of National defence.

immtech.net

ImmTech Inc. -- Index

206 High St, Suite 2. New Windsor, MD 21776. Quality source of ultrasensitive biodetection kits and reagents. Expert resource for advanced immunotechnology research and development. Exclusive distributor for FAS-detect ELISA and FAS-detect IHC. Influenza A Antigen Detection Kits. Influenza A Nucleoprotein Antigen Calibration Kit. Influenza A Virus Nucleoprotein (NP) Antibody Inhibition Test. Crypto and Giardia IMS Beads. E coli IMS Beads. FAS-detect™ IHC - A Monocional Antibody Specific for.

immtechlabs.com

Immunodiagnostic Consultants Inc.

Reading, PA 19601. IFA, ELISA, Rapid Tests. NEW Clinical Services - INDIA. Technical Info and Training. More info coming soon! 2014 Immunodiagnostic Consultants Inc.

immtechnology.com

www.immtechnology.com

immtechpharma.com

Immtech Pharmaceuticals, Inc.

To have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community. The infectious diseases market represents an estimated US$46 billion in annual sales. Learn about Immtech Pharmaceuticals:. Our history, proprietary technology platform, products and prospects. Go to Press Releases.

immtecnodue.it

Immobiliare Tecnodue agenzia immobiliare a Vercelli

Ottimo è il collegamento ferroviario, la tratta Torino - Milano è molto comoda per raggiungere i due importanti capoluoghi. Rustico / casale Vendita. 65000 250m 5 locali. 92000 80m 3 locali. Villetta a schiera Vendita. 93000 75m 2 locali. Tecnodue S.a.s. 2014 , P.IVA. Euro 10000.00 interamente versato. Corso de rege 14 Vercelli, Telefono: 0161219579.

immtecs.de

IMMTecS IMMOBILIENTECHNOLOGIE mit SYSTEM | Home

Auf den Internetseiten der IMMTecS - Immobilientechnologie mit System. Durch unsere langjährige Erfahrung im Bereich der Finanzdienstleistungen und Immobilien sind wir Ihr kompetenter Ansprechpartner. Auf den nachfolgenden Seiten informieren wir Sie über unsere Leistungen und unsere aktuellen Immobilienprojekte. Gern beantworten wir Ihre Fragen in sämtlichen Finanzangelegenheiten. Setzen Sie sich einfach mit uns in Verbindung! Wir können entspannt in die. Zukunft sehen, Dank IMMTecS!

immtekengineers.com

Immtek

Email us: info@immtekengineers.com. We are a leading supplier of Plastic machinery and related equipment, Injection mold and plastic custom molded parts to the plastics and tool making industries in India. We invite you to view our website, visit our Principal supplier’s websites, through the hyperlinks, and contact us for more in depth information and a personal follow up by one of our team. Babyplast has new standard specification for Clamp Tie bar distance : 122mm x 122mm. Building on the experience a...

immtel.com

Welcome immtel.com - BlueHost.com

Web Hosting - courtesy of www.bluehost.com.

immter7.deviantart.com

immter7 (immter6) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Digital Art / Student. Deviant for 2 Years. This deviant's full pageview. Last Visit: 120 weeks ago. By moving, adding and personalizing widgets.